Is Dr Reddys Laboratories stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Dr Reddys Laboratories pays dividends. Last time was Monday 12th of August 2024 where the investors holding the stock on Tuesday 30th of July 2024 were paid $0.47917 per share. Over the last 27 times between 2001 and 2024, Dr Reddys Laboratories has paid $7.13745 with an average of $0.26 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Dr Reddys Laboratories 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $7.94, you would have made a profit of $6.36 per share or 80.10%
Yes, the average daily trading liquidity for Dr Reddys Laboratories is $799 065 thousand. You should therefore be able to get in and out of your positions relatively fast.
Dr Reddys Laboratories has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.78, the company's ability to pay off the debt is good. Dr Reddys Laboratories has a good net profit margin of 17.79% and should have high tolerances against inflation.
We have calculated the inflation risk for Dr Reddys Laboratories to be low [0.1 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.